In vitro in NSCLC cell lines (A549 and H358), 48 h of treatment with 100 ng/mL visfatin enhances cell migration and invasion in the Boyden chamber via upregulation and activation of MMP2 and MMP9 [84]. The gene discussed is NAMPT; the disease is non-small cell lung carcinoma.